Cargando…
Modeling Low Muscle Mass Screening in Hemodialysis Patients
INTRODUCTION: Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based screening for such patients is challenging, especially considering the availability of equipment within dialysis facilities. We theref...
Autores principales: | Senzaki, Daiki, Yoshioka, Nobuo, Nagakawa, Osamu, Inayama, Emi, Nakagawa, Takafumi, Takayama, Hidehito, Endo, Toko, Nakajima, Fumitaka, Fukui, Masayoshi, Kijima, Yasuaki, Oyama, Yasuo, Kudo, Risshi, Toyama, Tadashi, Yamada, Yosuke, Tsurusaki, Kiyoshi, Aoyama, Naoki, Matsumura, Takayasu, Yamahara, Hideki, Miyasato, Kenro, Kitamura, Tetsuya, Ikenoue, Tatsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210080/ https://www.ncbi.nlm.nih.gov/pubmed/36273447 http://dx.doi.org/10.1159/000526866 |
Ejemplares similares
-
Effectiveness of music therapy for alleviating pain during haemodialysis access cannulation for patients undergoing haemodialysis: a multi-facility, single-blind, randomised controlled trial
por: Kishida, Masatsugu, et al.
Publicado: (2019) -
Letter to the Editor: Lack of requirements for conducting meta-analysis to evaluate the association between the TLR2 Arg753Gln polymorphism and the risk of sepsis
por: Tsujimoto, Yasushi, et al.
Publicado: (2016) -
Transfusion-dependent anaemia treatment using continuous erythropoietin receptor activator (epoetin β pegol) and roxadustat after darbepoetin treatment failure in low-risk myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2021) -
Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2017) -
Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2017)